Concepedia

Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000–01 FFCD/SFRO study

Bruno Chauffert, F. Mornex, F. Bonnetain, P. Rougier, C. Mariette, Olivier Bouché, J.-F. Bosset, Thomas Aparicio, Laurent Mineur, A. Azzedine,

Annals of Oncology · 2008 · 694 citations · 26 references

DOI

Concepts

References

26

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

Howard A. Burris, Malcolm J. Moore, John Sahl Andersen et al. · Journal of Clinical Oncology · 1997 · 5.9K citations

, , +16

A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer

John P. Neoptolemos, Deborah Stocken, Helmut Friess et al. · New England Journal of Medicine · 2004 · 2.7K citations

, , +16

Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer

Helmut Oettle, Stefan Post, P. Neuhaus et al. · JAMA · 2007 · 2.4K citations

, , +13

Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil. The gastrointestinal tumor study group

C G Moertel, Stephen Frytak, R. G. Hahn et al. · Cancer · 1981 · 1K citations

, , +13

Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer

Bengt Glimelius, Katarina Hoffman, Per‐Olow Sjödén et al. · Annals of Oncology · 1996 · 805 citations

, , +12